Citation: Dr. Catchpoole et Rb. Lock, The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma, EUR J CANC, 37(17), 2001, pp. 2217-2221
Authors:
Catts, VS
Farnsworth, ML
Haber, M
Norris, MD
Lutze-Mann, LH
Lock, RB
Citation: Vs. Catts et al., High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance, LEUKEMIA, 15(6), 2001, pp. 929-935
Authors:
Murphy, KM
Ranganathan, V
Farnsworth, ML
Kavallaris, M
Lock, RB
Citation: Km. Murphy et al., Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells, CELL DEAT D, 7(1), 2000, pp. 102-111
Citation: Km. Murphy et al., Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation, J BIOL CHEM, 275(23), 2000, pp. 17225-17228
Citation: Km. Murphy et al., Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2, ONCOGENE, 18(44), 1999, pp. 5991-5999
Authors:
Turnbull, RM
Meczes, EL
Rogers, MP
Lock, RB
Sullivan, DM
Finlay, GJ
Baguley, BC
Austin, CA
Citation: Rm. Turnbull et al., Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases II alpha and beta, CANC CHEMOT, 44(4), 1999, pp. 275-282
Authors:
Elliott, MJ
Murphy, KM
Stribinskiene, L
Ranganathan, V
Sturges, E
Farnsworth, ML
Lock, RB
Citation: Mj. Elliott et al., Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide, CANC CHEMOT, 44(1), 1999, pp. 1-11